Motagon

About

News and coverage

Announcements from Motagon and press coverage of the company.

  • Motagon receives EU-GMP Part I certification

    June 2026, Motagon adds EU-GMP Part I for finished medicinal products to the Part II authorisation held since 2022.

  • GPs can now prescribe medical cannabis for chronic pain

    From 1 April 2025, general practitioners with specialities 001 and 002 may prescribe for diagnosis R52.1.

    What this means for prescribers

  • Exclusive Curaleaf distribution in the Czech Republic

    Motagon becomes the exclusive Czech distributor for Curaleaf medical cannabis products.

  • First Czech supply of full-spectrum cannabis extracts

    Motagon becomes the first pharmaceutical company in the Czech Republic to supply medical cannabis extracts to patients.

Newsletter

Company news by email

Licence news, new products and batches, and events for healthcare professionals. A few emails a year, written by the team, and nothing promotional about prescription-only medicines to anyone who is not a healthcare professional.

Subscribe